The Cannabis Partnerships Congress (March 12–13, San Francisco) brings together stakeholders involved in Cannabis-based scientific, medicinal, governmental, and research development as to fortify the therapies in a collaborative environment. With the continued enforcement of restrictive policies and regulations on research into the health benefits, it is important for those involved to understand the obstacles in order to enhance product development.
This conference will showcase how to overcome legislative hurdles and current and planned cannabinoid research, and how to improve the quality and efficiency of data integrity in clinical trials.
The 9th Proactive GCP Compliance conference is taking place March 19–21 in Philadelphia. Register today to join senior-level colleagues from pharma, biotech, and device companies whose responsibilities include clinical quality, compliance, and operations, at what has become the industry’s only conference dedicated to proactive GCP compliance.
Successfully introducing new drugs and therapies in a quicker and more cost-effective manner starts in the most complex phase on of drug development; the clinical phase. The implementation of risk-based monitoring increases the overall quality of data while providing better oversight of patient safety. With the introduction of centralized monitoring in a risk-based monitoring approach, pharmaceutical companies are able to embrace a real-time overview of data and risk detection.
The Central Monitoring Summit will arm delegates with the tools they need to optimize existing clinical operation platforms and build quality into the design for a sound central monitoring foundation. Join your colleagues and our expert speaking staff as they provide in-depth insights into shifting your monitoring processes from an excessive concentration of data to risk-driven monitoring that uses central monitoring and technology enablement.
The Adaptive Clinical Trials Symposium, convening on March 22–23, 2018 in Philadelphia, is designed to provide attendees with innovative solutions that will deliver drugs to the market faster and at a low cost. Attendees will learn about creating a program development strategy that includes adaptive design. Join our fantastic, high-level speaking faculty who will tackle all of these challenges and more during this two-day event.
The 7th Digital Marketing for Medical Devices West conference — the #1 marketing event series for medical device professionals on the West Coast — returns to San Francisco April 23–25. Our extensive faculty of experts will discuss strategies to improve digital marketing effectiveness to hard-to-reach customers through customized, relevant and engaging marketing outreach. Come learn from and network with more than 120 attendees representing a diverse mix of medical device organizations. To learn more about the event — or to register — please click the linked buttons below.
Kelly Willenberg LLC is a full service research compliance organization serving clients on improving operations. She employs technologies to improve operational aspects of compliance based on client needs. She assists in the implementation of billing compliance programs, offers training seminars, builds coverage analysis and helps with process improvement. She can also assist with process improvement, quality assurance and assessing vulnerabilities in all aspects of research compliance.
FiercePharma is a digital media publication, reporting and delivering daily news and objective analysis for business professionals in global industries. FiercePharma offers broad coverage serving a wide range of specific functional interests, including manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline; and the influence of big data, executive moves and social media on it all.
MAPS is the premier non-profit global society of Medical Affairs professionals across a spectrum of fields, experience, and locales. With our non-profit status, MAPS is able to reinvest all revenue back into the society, which ensures our ability to create valuable programs and resources that support the Medical Affairs community. MAPS is transforming the Medical Affairs industry to increase its value to companies and, ultimately, benefit patients and consumers.
Applied Clinical Trials Shares Updates From CROWN Congress
Our friends over at Applied Clinical Trials Online recently shared updates gleaned from attending ExL Events‘ January 2018 CROWN Congress with their audience. This article exemplifies the benefits of attending an ExL conference and we thank the publication for sharing this information.
In addition to conferences, ExL Events also provides industry-related content through a variety of social platforms. Be sure to follow the profiles that fit your topics of interest to gain access to the latest content and industry news.
Fill out our form to receive topic-specific conference emails as well as updates.